News

Wednesday 16, 2009 - In this interview, Prof Peter Hoskin recaps the most interesting discussions of the meeting, comparing its success to that of the previous edition.

Friday, 11 December 2009- Pro and contra arguments on the benefits of prostate cancer screening were presented during the recent 2nd European Multidisciplinary Meeting on Urological Cancers (EMUC) with both camps debating a number of issues such as survival rates, QoL, risk of over treatment and...

Monday, 7 December 2009-  The issue of whether to choose for active surveillance (AS) or aggressive treatment in patients with small renal tumours is fraught with uncertainties. However, active surveillance has its own substantial risks and is not suited for younger patients, according to...

Joint meeting builds a solid foundation for multidisciplinary cooperation

Oncologist Prof. Johann De Bono is involved in search for new prostate cancer treatments 

“Late stage prostate cancer remains an obvious and large unmet clinical need”, says Prof. Johann De Bono, oncologist at The Royal Marsden Hospital in Sutton (UK). “It is good to see that during the 2nd...